These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 578398

  • 1. [Plasmatic thyroid hormones during treatment of hyperthyroidism by carbimazol (author's transl)].
    Linquette M, Lefebvre J, Benoit G, Racadot A.
    Ann Endocrinol (Paris); 1977; 38(2):169-70. PubMed ID: 578398
    [Abstract] [Full Text] [Related]

  • 2. [Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)].
    Lorcy Y, Heim J, Auvray E, Allannic H.
    Ann Endocrinol (Paris); 1979; 40(4):441-2. PubMed ID: 117739
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.
    Verhoeven RP, Visser TJ, Doctor R, Hennemann G, Schalekamp MA.
    J Clin Endocrinol Metab; 1977 May; 44(5):1002-5. PubMed ID: 576870
    [Abstract] [Full Text] [Related]

  • 5. Thyroid function tests during carbimazole therapy.
    Scott DL, Tymms DJ, Taylor MA, Chapman C.
    Postgrad Med J; 1980 Dec; 56(662):838-41. PubMed ID: 6894979
    [Abstract] [Full Text] [Related]

  • 6. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
    McIver B, Rae P, Beckett G, Wilkinson E, Gold A, Toft A.
    N Engl J Med; 1996 Jan 25; 334(4):220-4. PubMed ID: 8531998
    [Abstract] [Full Text] [Related]

  • 7. Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume.
    Pfeilschifter J, Ziegler R.
    Eur J Endocrinol; 1997 Jan 25; 136(1):81-6. PubMed ID: 9037131
    [Abstract] [Full Text] [Related]

  • 8. Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine.
    Erfurth EM, Hedner P.
    J Endocrinol Invest; 1986 Oct 25; 9(5):407-12. PubMed ID: 3794185
    [Abstract] [Full Text] [Related]

  • 9. T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
    Mastorakos G, Doufas AG, Mantzos E, Mantzos J, Koutras DA.
    J Endocrinol Invest; 2003 Oct 25; 26(10):979-84. PubMed ID: 14759070
    [Abstract] [Full Text] [Related]

  • 10. Measurement of free thyroxine and free triiodothyronine in thyrotoxicosis and hypothyroidism.
    Franklyn JA, Sheppard MC, Ramsden DB, Wilkinson R, Hoffenberg R.
    Clin Endocrinol (Oxf); 1984 Jan 25; 20(1):107-10. PubMed ID: 6420093
    [Abstract] [Full Text] [Related]

  • 11. Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen.
    Dahlberg PA, Karlsson FA, Lindström B, Wide L.
    Clin Endocrinol (Oxf); 1981 Jun 25; 14(6):555-62. PubMed ID: 6895351
    [Abstract] [Full Text] [Related]

  • 12. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K.
    J Clin Endocrinol Metab; 1981 Jul 25; 53(1):113-6. PubMed ID: 6165731
    [Abstract] [Full Text] [Related]

  • 13. [Preliminary results of T3 radioimmunoassay. Comparison with others serum parameters in diseases of the thyroid (author's transl)].
    Peyrin JO, Bornet H, Roux D.
    Ann Endocrinol (Paris); 1974 Jul 25; 35(3):271-2. PubMed ID: 4219108
    [No Abstract] [Full Text] [Related]

  • 14. [Changes in serum T3, T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease (author's transl)].
    Tamai H, Suematsu H, Esaki M, Kurakawa N, Aoki H.
    Nihon Naibunpi Gakkai Zasshi; 1977 Jan 20; 53(1):17-27. PubMed ID: 72007
    [No Abstract] [Full Text] [Related]

  • 15. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ, Williams DE, Orgiazzi J, Solomon DH.
    J Clin Endocrinol Metab; 1975 Nov 20; 41(5):911-20. PubMed ID: 1242390
    [Abstract] [Full Text] [Related]

  • 16. Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism.
    Laurberg P.
    J Clin Endocrinol Metab; 1987 May 20; 64(5):969-74. PubMed ID: 3558731
    [Abstract] [Full Text] [Related]

  • 17. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR.
    J Clin Endocrinol Metab; 1975 Dec 20; 41(06):1098-104. PubMed ID: 54364
    [Abstract] [Full Text] [Related]

  • 18. Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
    Golden MP, Kaplan SA, Lippe BM, Lee WN.
    Pediatrics; 1977 May 20; 59(5):762-7. PubMed ID: 577011
    [Abstract] [Full Text] [Related]

  • 19. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y.
    J Clin Endocrinol Metab; 1995 Jul 20; 80(7):2173-7. PubMed ID: 7608274
    [Abstract] [Full Text] [Related]

  • 20. Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease.
    MacFarlane IA, Davies D, Longson D, Shalet SM, Beardwell CG.
    Clin Endocrinol (Oxf); 1983 Jun 20; 18(6):557-61. PubMed ID: 6411390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.